Cantor Fitzgerald Downgrades Jasper Therapeutics (JSPR) to Neutral, 'Scratching our Heads with Today’s Briq’ Update'
Tweet Send to a Friend
(Updated - July 7, 2025 3:29 PM EDT)
Cantor Fitzgerald analyst Pete Stavropoulos downgraded Jasper Therapeutics (NASDAQ: JSPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Pete Stavropoulos downgraded Jasper Therapeutics (NASDAQ: JSPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
